trending Market Intelligence /marketintelligence/en/news-insights/trending/tqywpfz8eopk8lhtr7z9ba2 content esgSubNav
In This List

Scythian Biosciences adds board member

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Scythian Biosciences adds board member

Scythian Biosciences Corp. appointed Andrew DeFrancesco to its board of directors, effective Sept. 4.

DeFrancesco is chairman of Cool Holdings Inc., a Nasdaq-listed investment company.

Toronto-based Scythian Biosciences develops cannabis-derived treatments for concussions and traumatic brain injuries.